VEDA was founded by a unique group of experts in agricultural science, chemistry, biology, healthcare, and finance. VEDA has been developed to address the overwhelming deficiency in (ECN) that affects the health and well-being of individuals all over the world.
VEDA products are formulated to provide the highest bioavailability, the most effective delivery systems and to ensure customer accessibility and affordability. Driven by principles and quality, at VEDA we are dedicated to having a profound impact on humanity. We believe everyone should have access to quality ECN to enhance health.
VEDA ECN is a subsidiary of Avant Garde Holdings Americas, Inc., dba AG Health, a research and development company of bio-pharmaceutical products, big data analytics, health information and disease management, drug formulations and commerce solutions for the U.S. hemp industry.
For more information on AGH, visit our site https://vedaecn.com/